Pharmicell Co., Ltd.

KRX:005690.KS

5430 (KRW) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income 3,577.98410,884.7619,513.3385,241.8014,347.128-12,680.884-39,196.611-676.712-6,390.212-28,768.437-25,700.965-17,649.374-18,185.956-13,832.579-3,953.213-4,432.368-907.86
Depreciation & Amortization 2,841.4082,185.2611,735.8451,769.231,791.6791,623.0753,325.8223,346.2782,590.1952,787.2543,598.6192,845.1241,249.465436.103267.795535.282734.705
Deferred Income Tax 0000000471.7512,115.02319,722.1801,401.0212,500.1886,504.959000
Stock Based Compensation 0000000212.031844.191705.0780329.275415.866372.571000
Change In Working Capital 3,391.518-5,499.597-16,442.081-852.309-5,166.861836.093-1,308.249-2,352.714-1,754.511-4,470.776-363.454-1,117.318-3,954.718246.557-2,286.2695,807.592-1,816.035
Accounts Receivables 3,425.924-2,631.753-3,217.043-3,498.429-1,243.57502.001328.129275.073-1,980.97700000000
Inventory 2,365.964-4,596.092-10,553.1121,888.456-2,850.76863.903-1,538.156-1,109.551-203.7111,793.995411.8391,497.281-1,569.838-760.2981,997.1774,674.884-1,956.115
Accounts Payables -877.1231,817.854-1,133.6551,381.78-463.758346.628324.453-672.014756.83600000000
Other Working Capital -1,523.247-89.606-1,538.271-624.116-608.765772.19229.907-1,243.163-1,550.8-6,264.771-775.293-2,614.599-2,384.881,006.855-4,283.4461,132.708140.08
Other Non Cash Items 2,003.502344.023-29.3022,819.332-1,047.44513,626.70635,171.714-11.666184.1381,252.67419,778.0732,322.9221,808.749721.995830.322472.8991,243.525
Operating Cash Flow 11,814.4127,914.448-5,222.28,978.055-75.4993,404.989-2,007.324988.968-2,411.176-8,772.027-2,687.727-11,868.35-16,166.406-5,550.394-5,141.3652,383.405-745.665
Investing Activities:
Investments In Property Plant And Equipment -6,021.517-18,957.716-4,320.244-742.73-1,662.249-4,677.389-4,273.089-3,851.16-7,323.51-2,407.498-2,652.957-3,070.532-772.907-3,371.8-3,248.106-97.479-499.61
Acquisitions Net 1.8183.727.543-175.574-468.00416.6752-1,427.288-1,779.133-1,082.21401,090.1831,000.432-2,300-800-10,303.0430
Purchases Of Investments -16,119.08-15,632.213-5,406.738-6,155.556-90.195-4,068.0690-5,945.764-6,096.201-2,1800-4,256.822-4,776.021-946.517-1,229.045-1,886.576-89.798
Sales Maturities Of Investments 27,455.81214,093.612392.1923,240.97728.0222,388.2126,872.0735,012.445143.8362,736.71510,439.338575.986-90.466242.315.685,435.3180
Other Investing Activites 598.749-39.5-37.852228.04538.504-371.702471,855.0941,798.1933,542.7111,258.082-1,537.5193,748.434-244.6924,603.765-2.99917.769
Investing Cash Flow 5,915.783-20,532.117-9,345.099-3,604.844-1,653.922-6,712.2742,645.983-4,356.673-13,256.814609.7159,044.463-7,198.704-890.528-6,620.699-667.706-6,854.779-571.639
Financing Activities:
Debt Repayment -18,395.50-3,00000-2,604-3960-1,500-3,805-23,011.872-16,179.573-15,901.69-1,550-9,272.643-12,766.262-94.043
Common Stock Issued 000006,286.83103.761,021.2829,111.92624,511.1455,273.27832,819.2088,843.5391,426.23810,998.79113,999.9950
Common Stock Repurchased 000000000000-114.830000
Dividends Paid 00000000000000000
Other Financing Activities -317.626-269.80721,512.491-178.47502,604396008,0002,0009,85039,163.61812,537.71710,8194,421.651,428.826
Financing Cash Flow -18,713.126-269.80718,512.491-178.475-145.0538,890.83499.761,021.2827,611.92628,706.145-15,738.59526,489.63512,453.9512,413.95512,545.1485,655.3831,334.783
Other Information:
Effect Of Forex Changes On Cash 348.2381,034.8331,327.282-960.709-9.17-11.10527.4678.222-1.1220.4690-0000-0.0010
Net Change In Cash -634.693-11,852.6425,272.4754,234.027-1,883.6445,572.4411,165.879-2,268.201-8,057.18620,544.302-9,381.8587,422.581-4,602.984242.8626,736.0771,184.00817.479
Cash At End Of Period 13,724.08714,358.7826,211.42220,938.94816,704.9218,588.56513,016.12411,850.24514,118.44622,175.6321,631.3311,013.1883,590.6068,186.8467,943.9841,207.90723.899